de Vries IJ - Search Results

1

Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death.

Di Blasio S, Wortel IM, van Bladel DA, de Vries LE, Duiveman-de Boer T, Worah K, de Haas N, Buschow SI, de Vries IJ, Figdor CG, Hato SV. Di Blasio S, et al. Among authors: de vries le, de vries ij, de haas n. Oncoimmunology. 2016 Aug 3;5(8):e1192739. doi: 10.1080/2162402X.2016.1192739. eCollection 2016 Aug. Oncoimmunology. 2016. PMID: 27622063 Free PMC article.

2

Renal cell carcinoma-associated antigen G250 encodes a naturally processed epitope presented by human leukocyte antigen-DR molecules to CD4(+) T lymphocytes.

Vissers JL, De Vries IJ, Engelen LP, Scharenborg NM, Molkenboer J, Figdor CG, Oosterwijk E, Adema GJ. Vissers JL, et al. Among authors: de vries ij. Int J Cancer. 2002 Aug 1;100(4):441-4. doi: 10.1002/ijc.10518. Int J Cancer. 2002. PMID: 12115527 Free article.

3

Phenotypical and functional characterization of clinical grade dendritic cells.

de Vries IJ, Eggert AA, Scharenborg NM, Vissers JL, Lesterhuis WJ, Boerman OC, Punt CJ, Adema GJ, Figdor CG. de Vries IJ, et al. J Immunother. 2002 Sep-Oct;25(5):429-38. doi: 10.1097/00002371-200209000-00007. J Immunother. 2002. PMID: 12218781

4

Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state.

De Vries IJ, Krooshoop DJ, Scharenborg NM, Lesterhuis WJ, Diepstra JH, Van Muijen GN, Strijk SP, Ruers TJ, Boerman OC, Oyen WJ, Adema GJ, Punt CJ, Figdor CG. De Vries IJ, et al. Cancer Res. 2003 Jan 1;63(1):12-7. Cancer Res. 2003. PMID: 12517769

5

Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.

de Vries IJ, Lesterhuis WJ, Scharenborg NM, Engelen LP, Ruiter DJ, Gerritsen MJ, Croockewit S, Britten CM, Torensma R, Adema GJ, Figdor CG, Punt CJ. de Vries IJ, et al. Clin Cancer Res. 2003 Nov 1;9(14):5091-100. Clin Cancer Res. 2003. PMID: 14613986

6

Dendritic cell immunotherapy: mapping the way.

Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Figdor CG, et al. Among authors: de vries ij. Nat Med. 2004 May;10(5):475-80. doi: 10.1038/nm1039. Nat Med. 2004. PMID: 15122249 Review.

7

Phenotypical and functional characterization of clinical-grade dendritic cells.

de Vries IJ, Adema GJ, Punt CJ, Figdor CG. de Vries IJ, et al. Methods Mol Med. 2005;109:113-26. doi: 10.1385/1-59259-862-5:113. Methods Mol Med. 2005. PMID: 15585917 Review.

8

Migration of dendritic cell based cancer vaccines: in vivo veritas?

Adema GJ, de Vries IJ, Punt CJ, Figdor CG. Adema GJ, et al. Among authors: de vries ij. Curr Opin Immunol. 2005 Apr;17(2):170-4. doi: 10.1016/j.coi.2005.01.004. Curr Opin Immunol. 2005. PMID: 15766677 Review.

9

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.

Tacken PJ, de Vries IJ, Gijzen K, Joosten B, Wu D, Rother RP, Faas SJ, Punt CJ, Torensma R, Adema GJ, Figdor CG. Tacken PJ, et al. Among authors: de vries ij. Blood. 2005 Aug 15;106(4):1278-85. doi: 10.1182/blood-2005-01-0318. Epub 2005 May 5. Blood. 2005. PMID: 15878980 Free article.

10

Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome.

de Vries IJ, Bernsen MR, Lesterhuis WJ, Scharenborg NM, Strijk SP, Gerritsen MJ, Ruiter DJ, Figdor CG, Punt CJ, Adema GJ. de Vries IJ, et al. J Clin Oncol. 2005 Aug 20;23(24):5779-87. doi: 10.1200/JCO.2005.06.478. J Clin Oncol. 2005. PMID: 16110035 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page